Bristol-myers Squibb Co. share price logo

Bristol-myers Squibb Co. Share Price

NYSE: BMY

Large Cap

$59.07

+0.12

(+0.20%)

as on

Bristol-myers Squibb Co. Stock Performance

as on March 14, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $58.75
    $60.06
    downward going graph

    0.54%

    Downside

    1.68%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $42.52
    $62.89
    downward going graph

    28.02%

    Downside

    6.46%

    Upside

    downward going graph

Bristol-myers Squibb Co. share price movements today

Previous Close
$58.95
Open
$59.50
Volume
7.1M
Day's Low - High
$58.75 - $60.06
52 Week Low - High
$42.52 - $62.89

Bristol-myers Squibb Co. Historical Returns

1 Month Return
-2.73 %
3 Month Return
+ 12.73 %
1 Year Return
+ 0.12 %
3 Year Return
-11.12 %
5 Year Return
-2.57 %

Bristol-myers Squibb Co. Stock Fundamentals & Key Indicators

Check Bristol-myers Squibb Co. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$120.3B

EPS (TTM)

6.2701

Dividend Yield

4.67%

Quarterly Earnings Growth YOY

13.92%

PE Ratio (TTM)

17.08

Industry PE ratio

17.7675641025641

PEG Ratio

2.2562

EBITDA

19.1B

Revenue (TTM)

48.2B

Profit Margin

14.64%

Return On Equity TTM

40.44%

Bristol-myers Squibb Co. Stock Valuation

Track how Bristol-myers Squibb Co. P/E has moved over time to understand its valuation trends.

Bristol-myers Squibb Co. in the last 5 years

  • Overview

  • Trends

Lowest (7.10x)

December 31, 2023

Today (17.08x)

March 14, 2026

Industry (17.77x)

March 14, 2026

Highest (54.19x)

March 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 17.08x

Bristol-myers Squibb Co. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Bristol-myers Squibb Co. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Bristol-myers Squibb Co. image
Bristol-myers Squibb Co.
HOLD$120.3B-2.57%17.0814.64%
Eli Lilly And Company image
Eli Lilly And Company
BUY$881.7B373.41%42.9231.67%
ASTRAZENECA PLC image
ASTRAZENECA PLC
BUY$298.4B292.19%29.3917.41%
Johnson & Johnson image
Johnson & Johnson
BUY$583.3B51.33%21.9428.46%
Abbvie Inc image
Abbvie Inc
BUY$398.5B102.99%95.096.91%
See all

Stock Returns calculator for Bristol-myers Squibb Co. Stock including INR - Dollar returns

The Bristol-myers Squibb Co. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Bristol-myers Squibb Co. investment value today

Current value as on today

₹1,06,478

Returns

₹6,478

(+6.48%)

Returns from Bristol-myers Squibb Co. Stock

₹102 (+0.10%)

Dollar Returns*

₹6,376 (+6.38%)

Analyst Recommendation on Bristol-myers Squibb Co. Stock

Based on 31 analysts

HOLD

32.26%

Buy

64.52%

Hold

3.23%

Sell

Based on 31 analysts, 64.52% of analysts recommend a 'HOLD' rating for Bristol-myers Squibb Co.. Average target price of $62.36

Bristol-myers Squibb Co. Share Price Target

Get share price movements and forecasts by analysts on Bristol-myers Squibb Co..

What analysts predicted

5.28%UPSIDE

Target Price

$62.36

Current Price

$59.07

Analyzed by

31 Analysts

Target

$62.36

Bristol-myers Squibb Co. target price $62.36, a slight upside of 5.28% compared to current price of $59.07. According to 31 analysts rating.

Bristol-myers Squibb Co. Stock’s Investor Sentiment and Interest

Investment in Bristol-myers Squibb Co. Shares on INDmoney has grown by 17.18% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:17.18% versus previous 30 day period

Search interest for Bristol-myers Squibb Co. Stock has decreased by -6% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-6% versus previous 30 day period

Bristol-myers Squibb Co. Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10,966
11,477
11,865
12,201
11,892
12,342
11,201
12,269
12,222
12,502
Gross Profit
6,220
6,492
6,590
6,801
6,617
7,424
7,340
8,070
8,787
8,405
Operating Income
2,104
1,952
1,535
2,584
2,288
2,531
3,521
4,117
3,639
1,419
EBITDA
4,852
4,454
-8,559
4,403
4,773
2,551
4,477
3,287
4,587
2,194
Interest Expense
280
316
425
521
505
496
494
485
480
51
Depreciation
2,435
2,464
2,532
2,596
2,592
1,880
1,012
1,011
1,011
977
Income Before Tax
2,137
1,674
-11,516
1,286
1,676
175
2,971
1,773
3,114
1,470
Income Tax Expense
203
-88
392
-398
461
99
509
460
919
384
Net Income
1,928
1,762
-11,911
1,680
1,211
72
2,456
1,310
2,201
1,086
Net Profit Margin
17.58%
15.35%
-100.39%
13.77%
10.18%
0.58%
21.93%
10.68%
18.01%
8.69%

Bristol-myers Squibb Co. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
19,427
20,776
22,561
26,145
42,518
46,385
46,159
45,006
48,300
48,194
Gross Profit
14,495
14,958
16,075
17,250
21,700
26,761
26,490
25,357
27,432
32,602
Operating Income
5,179
5,239
6,394
6,439
4,492
9,540
9,271
8,472
9,658
12,696
EBITDA
6,464
6,116
6,788
7,377
4,929
20,118
19,221
19,366
3,168
14,545
Interest Expense
167
196
183
656
1,420
1,334
1,232
1,166
1,947
1,510
Depreciation
-
789
637
1,746
10,380
10,023
9,595
9,817
9,600
4,011
Income Before Tax
5,915
5,131
5,968
4,975
-6,871
8,098
7,713
8,440
-8,379
9,328
Income Tax Expense
1,408
4,156
1,021
1,515
2,124
1,084
1,368
400
554
2,272
Net Income
4,457
1,007
4,920
3,439
-8,995
6,994
6,327
8,025
-8,948
7,053
Net Profit Margin
22.94%
4.85%
21.81%
13.15%
-21.16%
15.08%
13.71%
17.83%
-18.53%
14.63%

Bristol-myers Squibb Co. Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
1,762
-11,908
1,684
1,215
76
2,462
1,313
2,195
1,085
Operating Cash Flow
4,252
2,834
2,326
5,591
4,439
1,954
3,917
6,311
1,974
Investing Cash Flow
-1,346
-19,618
-1,319
-219
-196
-499
-473
-1,702
-1,458
Financing Cash Flow
967
14,644
-4,023
-3,852
-1,642
-993
-1,836
-1,490
-6,029
Change in Cash
3,951
-2,185
-3,038
1,597
2,454
528
1,736
3,115
-5,508

Bristol-myers Squibb Co. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
975
4,947
3,460
-8,995
7,014
6,345
8,040
-8,933
7,055
Operating Cash Flow
5,275
7,066
8,067
14,052
16,207
13,066
13,860
15,190
14,156
Investing Cash Flow
-66
-2,000
-9,770
-10,859
-538
-1,062
-2,295
-21,352
-4,132
Financing Cash Flow
-4,077
-3,535
7,621
-1,151
-16,224
-16,962
-9,416
5,127
-10,348
Change in Cash
1,184
1,490
5,909
2,153
-657
-4,991
2,194
-1,172
-137

Mutual Funds that own Bristol-myers Squibb Co. Stock

Check out the Mutual Funds with significant holdings in Bristol-myers Squibb Co..

Global Institutional Holdings in Bristol-myers Squibb Co.

Funds
Holdings
PRIMECAP Management Company
1.22%
Bank of New York Mellon Corp
1.02%
UBS Asset Mgmt Americas Inc
1.07%
State Street Corp
4.74%
Geode Capital Management, LLC
2.29%
See all

Bristol-myers Squibb Co. News & Key Events

  • img

    Today's Timeline - 12 March

    Thu, 12:06 PM

    -

    Piper Sandler raises BMY price target to $75, citing growth potential post-Eliquis patent expiry and pipeline advancements.

    Thu, 09:44 PM

    -

    BMY reports positive interim results for mezigdomide, highlighting a promising pipeline with multiple candidates for future growth.

Insights on Bristol-myers Squibb Co.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Bristol-Myers Squibb Co. has shown a positive trend in its revenue over the last two quarters. Revenue increased from $12.22 billion to $12.50 billion, with an average growth of 2.2% per quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, BMY stock has moved up by 27.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, ASTRAZENECA PLC has given 144.7% return, outperforming this stock by 144.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Eli Lilly And Company has given 194.1% return, outperforming this stock by 206.5%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Bristol-Myers Squibb Co. has experienced a decline in net profit over the last two quarters. In the most recent quarter, the net profit dropped to $1.08 billion from $2.20 billion. This represents an average decrease of 50.7% per quarter.

About Bristol-myers Squibb Co.

The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
OrganisationBristol-myers Squibb Co.
HeadquartersRoute 206 & Province Line Road, Princeton, NJ, United States, 08543
IndustryHealth Technology
CEODr. Christopher S. Boerner Ph.D.
E-voting on sharesClick here to vote

Key Management of Bristol-myers Squibb Co.

Name

Title

Mr. Greg Meyers

Executive VP and Chief Digital & Technology Officer

Ms. Ahn Amanda Poole

Executive VP & Chief People Officer

Dr. Joseph J. Eiden Jr.

Head of Medical Affairs

Ms. Cari Gallman

Executive VP, General Counsel & Chief Policy Officer

Mr. Adam Lenkowsky

Executive VP & Chief Commercialization Officer

Ms. Wendy Short Bartie

Executive Vice President of Corporate Affairs

Dr. Christopher S. Boerner Ph.D.

CEO & Chairman

Mr. David V. Elkins

Executive VP & CFO

Ms. Karin Shanahan

Executive VP, Chief Supply Chain & Operations Officer

Mr. Charles E. Triano

SVP & Head of Investor Relations

FAQs

What is Bristol-myers Squibb Co. share price today?

Bristol-myers Squibb Co. share price today is $59.07 as on at the close of the market. Bristol-myers Squibb Co. share today touched a day high of $60.06 and a low of $58.75.

What is the 52 week high and 52 week low for Bristol-myers Squibb Co. share?

Bristol-myers Squibb Co. share touched a 52 week high of $62.89 on and a 52 week low of $42.52 on . Bristol-myers Squibb Co. stock price today i.e. is closed at $59.07,which is 6.07% down from its 52 week high and 38.92% up from its 52 week low.

What is Bristol-myers Squibb Co.'s market capitalisation today?

Bristol-myers Squibb Co. market capitalisation is $0.12T as on .

How to invest in Bristol-myers Squibb Co. Stock (BMY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Bristol-myers Squibb Co. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Bristol-myers Squibb Co. Shares that will get you 0.0254 shares as per Bristol-myers Squibb Co. share price of $59.07 per share as on March 14, 2026 at 1:29 am IST.

What is the minimum amount required to buy Bristol-myers Squibb Co. Stock (BMY) from India?

Indian investors can start investing in Bristol-myers Squibb Co. (BMY) shares with as little as ₹92.49 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹924.90 in Bristol-myers Squibb Co. stock (as per the Rupee-Dollar exchange rate as on ). Based on Bristol-myers Squibb Co. share’s latest price of $59.07 as on March 14, 2026 at 1:29 am IST, you will get 0.1693 shares of Bristol-myers Squibb Co.. Learn more about fractional shares .

What are the returns that Bristol-myers Squibb Co. has given to Indian investors in the last 5 years?

Bristol-myers Squibb Co. stock has given -2.57% share price returns and 27.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?